Profiling of substrate specificities of 3C-like proteases from group 1, 2a, 2b, and 3 coronaviruses

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Chuck, Chi Pang ^a   Chow, Hak Fun ^a   Wan, David Chi Cheong ^a   Wong, Kam Bo ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GLUTAMINE; GLYCINE; LEUCINE; PHENYLALANINE; POLYPROTEIN; PROTEINASE; SERINE; VALINE; PEPTIDE HYDROLASE;

ALPHACORONAVIRUS; AMINO ACID SEQUENCE; ARTICLE; BETACORONA VIRUS; CATALYSIS; CONTROLLED STUDY; CORONAVIRUS; ENZYME ACTIVITY; ENZYME SPECIFICITY; GAMMACORONA VIRUS; HYDROPHOBICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DEGRADATION; SPECIES DIVERSITY; VIRUS REPLICATION; CHEMICAL STRUCTURE; CLASSIFICATION; ENZYMOLOGY; GENETICS; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS;

AVIAN INFECTIOUS BRONCHITIS VIRUS; SARS CORONAVIRUS;

CLONING, MOLECULAR; CORONAVIRUS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE HYDROLASES; SUBSTRATE SPECIFICITY;

EID: 80355146292     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027228     Document Type: Article

References (38)

1. van der Hoek L, Pyrc K, Jebbink MF, Vermeulen-Oost W, Berkhout RJ, et al. (2004) Identification of a new human coronavirus. Nat Med 10: 368-373.
2. Hamre D, Procknow JJ, (1966) A new virus isolated from the human respiratory tract. Proc Soc Exp Biol Med 121: 190-193.
3. Woo PC, Lau SK, Chu CM, Chan KH, Tsoi HW, et al. (2005) Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol 79: 884-895.
4. Kuiken T, Fouchier RA, Schutten M, Rimmelzwaan GF, van Amerongen G, et al. (2003) Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362: 263-270.
5. Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, et al. (2003) Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361: 1319-1325.
6. Cheever FS, Daniels JB, Pappenheimer AM, Bailey OT, (1949) A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin. J Exp Med 90: 181-210.
7. Binn LN, Lazar EC, Keenan KP, Huxsoll DL, Marchwicki RH, et al. (1974) Recovery and characterization of a coronavirus from military dogs with diarrhea. Proc Annu Meet U S Anim Health Assoc pp. 359-366.
8. Poon LL, Chu DK, Chan KH, Wong OK, Ellis TM, et al. (2005) Identification of a novel coronavirus in bats. J Virol 79: 2001-2009.
9. Beaudette FR, Hudson CB, (1937) Cultivation of the virus of infectious bronchitis. J Am Vet Med Assoc 90: 51-58.
10. Doyle LP, Hutchings LM, (1946) A transmissible gastroenteritis virus in pigs. J Am Vet Assoc 108: 257-259.
11. Tyrrell DA, Bynoe ML, (1966) Cultivation of viruses from a high proportion of patients with colds. Lancet 1: 76-77.
12. Woo PC, Lau SK, Huang Y, Yuen KY, (2009) Coronavirus diversity, phylogeny and interspecies jumping. Exp Biol Med (Maywood) 234: 1117-1127.
13. Snijder EJ, Bredenbeek PJ, Dobbe JC, Thiel V, Ziebuhr J, et al. (2003) Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol 331: 991-1004.
14. Gorbalenya AE, Snijder EJ, Spaan WJ, (2004) Severe acute respiratory syndrome coronavirus phylogeny: toward consensus. J Virol 78: 7863-7866.
15. Gaunt ER, Hardie A, Claas EC, Simmonds P, Templeton KE, (2010) Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J Clin Microbiol 48: 2940-2947.
16. Dominguez SR, Robinson CC, Holmes KV, (2009) Detection of four human coronaviruses in respiratory infections in children: a one-year study in Colorado. J Med Virol 81: 1597-1604.
17. Cavanagh D, (2007) Coronavirus avian infectious bronchitis virus. Vet Res 38: 281-297.
18. Ignjatovic J, Sapats S, (2000) Avian infectious bronchitis virus. Rev Sci Tech 19: 493-508.
19. Lin CW, Tsai CH, Tsai FJ, Chen PJ, Lai CC, et al. (2004) Characterization of trans- and cis-cleavage activity of the SARS coronavirus 3CLpro protease: basis for the in vitro screening of anti-SARS drugs. FEBS Lett 574: 131-137.
20. Yang H, Xie W, Xue X, Yang K, Ma J, et al. (2005) Design of wide-spectrum inhibitors targeting coronavirus main proteases. PLoS Biol 3: e324.
21. Li SY, Chen C, Zhang HQ, Guo HY, Wang H, et al. (2005) Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res 67: 18-23.
22. Wu CY, Jan JT, Ma SH, Kuo CJ, Juan HF, et al. (2004) Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc Natl Acad Sci U S A 101: 10012-10017.
23. Chen L, Gui C, Luo X, Yang Q, Gunther S, et al. (2005) Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. J Virol 79: 7095-7103.
24. Fan K, Ma L, Han X, Liang H, Wei P, et al. (2005) The substrate specificity of SARS coronavirus 3C-like proteinase. Biochem Biophys Res Commun 329: 934-940.
25. Goetz DH, Choe Y, Hansell E, Chen YT, McDowell M, et al. (2007) Substrate specificity profiling and identification of a new class of inhibitor for the major protease of the SARS coronavirus. Biochemistry 46: 8744-8752.
26. Chuck CP, Chong LT, Chen C, Chow HF, Wan DC, et al. (2010) Profiling of substrate specificity of SARS-CoV 3CLpro. PLoS ONE 5: e13197.
27. Hegyi A, Ziebuhr J, (2002) Conservation of substrate specificities among coronavirus main proteases. J Gen Virol 83: 595-599.
28. Lee S, Tikhomirova A, Shalvardjian N, Chalikian TV, (2008) Partial molar volumes and adiabatic compressibilities of unfolded protein states. Biophys Chem 134: 185-199.
29. Kyte J, Doolittle RF, (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157: 105-132.
30. Chou PY, Fasman GD, (1978) Prediction of the secondary structure of proteins from their amino acid sequence. Adv Enzymol Relat Areas Mol Biol 47: 45-148.
31. Xue X, Yu H, Yang H, Xue F, Wu Z, et al. (2008) Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design. J Virol 82: 2515-2527.
32. Anand K, Ziebuhr J, Wadhwani P, Mesters JR, Hilgenfeld R, (2003) Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 300: 1763-1767.
33. Zhao Q, Li S, Xue F, Zou Y, Chen C, et al. (2008) Structure of the main protease from a global infectious human coronavirus, HCoV-HKU1. J Virol 82: 8647-8655.
34. Jenkins GM, Rambaut A, Pybus OG, Holmes EC, (2002) Rates of molecular evolution in RNA viruses: a quantitative phylogenetic analysis. J Mol Evol 54: 156-165.
35. Lai MM, (1992) RNA recombination in animal and plant viruses. Microbiol Rev 56: 61-79.
36. Pasternak AO, Spaan WJ, Snijder EJ, (2006) Nidovirus transcription: how to make sense..? J Gen Virol 87: 1403-1421.
37. Duffy S, Shackelton LA, Holmes EC, (2008) Rates of evolutionary change in viruses: patterns and determinants. Nat Rev Genet 9: 267-276.
38. Zhu L, George S, Schmidt MF, Al-Gharabli SI, Rademann J, et al. (2011) Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease. Antiviral Res doi:10.1016/j.antiviral.2011.08.001.